Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CelemicsXKRX:331920 -0.07%46 OCF Yield % is -2.38 as of Sep. 03, 2026. GuruFocus rates XKRX:331920 with a GF Score™ of 46/100 and a GF Value™ of ₩2,756.25 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Celemics ranks worse than 66.24% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Celemics's OCF Yield % or its related term are showing as below:
XKRX:331920'
s OCF Yield % Range Over the Past 10 Years
Min: -16.33 Med: -4.84 Max: -0.31
Current: -2.38
During the past 10 years, the highest OCF Yield % of Celemics was -0.31%. The lowest was -16.33%. And the median was -4.84%.
XKRX:331920's OCF Yield % is ranked worse than 66.24% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 1.785
vs XKRX:331920: -2.38
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Celemics OCF Yield % Related Terms
Celemics OCF Yield % Historical Data
* Premium members only.
The historical data trend for Celemics's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:331920 vs ABT, SYK, MDT: OCF Yield % Comparison
For the Medical Devices subindustry, Celemics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Celemics OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Celemics's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Celemics's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Celemics (XKRX:331920) has a OCF Yield % of -2.38 as of Sep. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Celemics and its competitors. According to the industry distribution chart, Celemics ranks #563 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 66.2%.
Is Celemics' OCF Yield % too high?
Celemics' current OCF Yield % is -2.38. Based on the distribution chart, Celemics ranks #563 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Celemics has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Celemics' OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Celemics ranks #563 out of 850 companies for OCF Yield %. This places Celemics in the lower half of its industry. The industry median OCF Yield % is 1.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Celemics and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Celemics's current OCF Yield % is -2.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celemics stock overvalued right now?
Based on GuruFocus' analysis, Celemics (XKRX:331920) is currently considered Significantly Overvalued. The stock's GF Value™ is ₩2,756.25, compared to a current price of ₩14,350.00 — trading 420.6% above its estimated fair value. The current OCF Yield % is -2.38. Celemics' overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Celemics (XKRX:331920), the current OCF Yield % is -2.38 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Celemics (XKRX:331920) Overvalued in 2026?
Based on GuruFocus' analysis, Celemics stock appears to be overvalued.
The current stock price of ₩14,350.00 is trading 420.6% above its estimated GF Value™ of ₩2,756.25.
GuruFocus considers Celemics to be Significantly Overvalued.
Key valuation signals for XKRX:331920:
OCF Yield %: -2.38
GF Value™: ₩2,756.25 vs. price of ₩14,350.00 (420.6% above fair value)
No single metric tells the full story. See the XKRX:331920 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Celemics Inc is a manufacturer of Next Generation Sequencing test kit. It offers, develops and manufactures proprietary DNA and genetic sequencing test kits and panels. Its products include Targeted Sequencing Kit, NGS Library Preparation Kit, and XSEP MagBead.
46GF Score
Get the complete analysis for XKRX:331920
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:331920 has been successfully added to your 
